|
Lipids and Lipid Disorders
Citations 101-110 of 193 total displayed.
|
Past content
(since Jan 1998):
|
- Editor's Correspondence
Possible Differences Between Fibrates in Pharmacokinetic Interactions With Statins
- Christie M. Ballantyne; Michael H. Davidson
Arch Intern Med 2003; 163: 2394-2395.
[Extract]
[Full text]
[PDF]
- Clinical Observations
Lifetime Risk of Coronary Heart Disease by Cholesterol Levels at Selected Ages
- Donald M. Lloyd-Jones; Peter W. F. Wilson; Martin G. Larson; Eric Leip; Alexa Beiser; Ralph B. D'Agostino; James I. Cleeman; Daniel Levy
Arch Intern Med 2003; 163: 1966-1972.
[Abstract]
[Full text]
[PDF]
- Original Investigations
Regression of Carotid and Femoral Artery Intima-Media Thickness in Familial Hypercholesterolemia: Treatment With Simvastatin
- Pernette R. W. de Sauvage Nolting; Eric de Groot; Aeilko H. Zwinderman; Rudolf J. A. Buirma; Mieke D. Trip; John J. P. Kastelein
Arch Intern Med 2003; 163: 1837-1841.
[Abstract]
[Full text]
[PDF]
- Original Investigations
High-Density vs Low-Density Lipoprotein Cholesterol as the Risk Factor for Coronary Artery Disease and Stroke in Old Age
- Annelies W. E. Weverling-Rijnsburger; Iris J. A. M. Jonkers; Eric van Exel; Jacobijn Gussekloo; Rudi G. J. Westendorp
Arch Intern Med 2003; 163: 1549-1554.
[Abstract]
[Full text]
[PDF]
- Original Investigations
Contemporary Awareness and Understanding of Cholesterol as a Risk Factor: Results of an American Heart Association National Survey
- Ira S. Nash; Lori Mosca; Roger S. Blumenthal; Michael H. Davidson; Sidney C. Smith Jr; Richard C. Pasternak
Arch Intern Med 2003; 163: 1597-1600.
[Abstract]
[Full text]
[PDF]
- Original Investigations
Cholesterol-Lowering Effect of a Theaflavin-Enriched Green Tea Extract: A Randomized Controlled Trial
- David J. Maron; Guo Ping Lu; Nai Sheng Cai; Zong Gui Wu; Yue Hua Li; Hui Chen; Jian Qiu Zhu; Xue Juan Jin; Bert C. Wouters; Jian Zhao
Arch Intern Med 2003; 163: 1448-1453.
[Abstract]
[Full text]
[PDF]
- Review Articles
Interactions Between the Renin-Angiotensin System and Dyslipidemia: Relevance in the Therapy of Hypertension and Coronary Heart Disease
- Balkrishna M. Singh; Jawahar L. Mehta
Arch Intern Med 2003; 163: 1296-1304.
[Abstract]
[Full text]
[PDF]
- Original Investigations
Plasma Total Cholesterol Level as a Risk Factor for Alzheimer Disease: The Framingham Study
- Zaldy Sy Tan; Sudha Seshadri; Alexa Beiser; Peter W. F. Wilson; Douglas P. Kiel; Michael Tocco; Ralph B. D'Agostino; Philip A. Wolf
Arch Intern Med 2003; 163: 1053-1057.
[Abstract]
[Full text]
[PDF]
- Original Investigations
Disparities in Use of Lipid-Lowering Medications Among People With Type 2 Diabetes Mellitus
- Monika Safford; Laura Eaton; Gerald Hawley; Michael Brimacombe; Mangala Rajan; Huiling Li; Leonard Pogach
Arch Intern Med 2003; 163: 922-928.
[Abstract]
[Full text]
[PDF]
- Review Articles
Differential Effects of Lipid-Lowering Therapies on Stroke Prevention: A Meta-analysis of Randomized Trials
- Jean-Christophe Corvol; Anissa Bouzamondo; Marc Sirol; Jean-Sébastien Hulot; Paola Sanchez; Philippe Lechat
Arch Intern Med 2003; 163: 669-676.
[Abstract]
[Full text]
[PDF]
|
|
